personalised medicine

News

FDA unveils swift route to market for personalised drugs

FDA reveals a regulatory pathway for personalised therapies based on 'plausible mechanism', drawing on the bespoke gene-editing treatment of Baby KJ.

R&D

Cell work representation, under a microscope

Unlocking the future of neurodegeneration research: How auto...

On the emergence of brain organoids and the advent of automation, the latter being essential for high-throughput approaches drug development demands.

Digital

Spatialomics and AI: A new age for personalised clinical med...

Digital

What is the future of technology in health data?

From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things.

News

KJ's parents, Kyle and Nicole, and his three siblings

World first as infant gets personalised CRISPR therapy

In a medical breakthrough, a child diagnosed with a rare genetic disorder has received a bespoke CRISPR gene editing therapy to correct the mutation.

R&D

Revolutionising personalised medicine: How IRT platforms are...

Cell and gene therapies offers transformative benefits to patients, including revolutionary treatment potential for cancer, AIDS, and hereditary diseases.